| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |